Financial News
Press Releases about Edgewise Therapeutics Inc
![](https://mms.businesswire.com/media/20230329005975/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230321005037/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230314005303/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230306005065/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230301005018/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230228005215/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230223005253/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230207005069/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230104005249/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20221221005112/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20221220005213/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20221109005318/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at Upcoming Investor Conferences
November 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221103005363/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Reports Third Quarter 2022 Financial Results
November 03, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221027006078/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20221013005743/en/1601418/5/NSAA_and_NSAD_EDG-5506_FINAL.jpg)
![](https://mms.businesswire.com/media/20221006005225/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220915006140/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220913006310/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
September 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220912005990/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Announces Proposed Offering of Common Stock
September 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220911005054/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220907005188/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220804005273/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220803005077/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220712005142/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220620005099/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220616005291/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220531005057/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220511005067/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220503005013/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.